Clinical Trials on Visual Acuity Reduced Transiently in Japan
Total 16 results
-
Janssen Pharmaceutical K.K.WithdrawnMacular Degeneration | Geographic Atrophy | Visual AcuityJapan
-
University of YamanashiNot yet recruiting
-
Institute for Clinical Effectiveness, JapanGlaxoSmithKlineRecruitingAcute Disease | Respiratory Syncytial Virus (RSV) | Respiratory Viral InfectionJapan
-
Rohto Pharmaceutical Co., Ltd.CompletedSevere Acute Respiratory Syndrome Coronavirus 2Japan
-
AstraZenecaCompletedAcute Ischaemic Stroke | Transient Ischaemic AttackSweden, United States, Australia, Brazil, Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, Vietnam, Germany, Philippines, China, Hungary, Romania, Ukraine, Hong Kong, Argentina, Bel... and more
-
TakedaCompletedPrevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Japan
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, Brazil, France, Slovakia, ... and more
-
Bristol-Myers SquibbJanssen, LPCompletedAcute Ischemic Stroke | Transient Ischemic Attack (TIA)France, Germany, Russian Federation, United States, China, Hong Kong, Korea, Republic of, Greece, Israel, Canada, Argentina, Australia, Austria, Belgium, Brazil, Chile, Czechia, Denmark, Finland, Hungary, Italy, Japan, Mexico, Norway, P... and more
-
NobelpharmaCompleted
-
National Center for Global Health and Medicine,...Active, not recruitingCovid19 | Urine | Acute Respiratory Failure With Hypoxia | BiomarkerUnited States, Brazil, Denmark, Japan, Philippines
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsCompletedCOVID-19 | COVID | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)Spain, United States, Denmark, United Kingdom, Greece, Japan, Nigeria
-
U.S. Army Medical Research and Development CommandNo longer availableTreatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)Severe Acute Respiratory Syndrome Coronavirus 2United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
-
Alexion PharmaceuticalsTerminatedPneumonia, Viral | Acute Respiratory Distress Syndrome | Acute Lung Injury | COVID-19 Severe PneumoniaUnited States, Spain, United Kingdom, France, Japan
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
AstraZenecaRecruitingViral Lung Infection and Acute Respiratory FailureUnited States, China, Australia, Czechia, Denmark, Hungary, Israel, Spain, United Kingdom, Canada, Germany, Italy, Argentina, Bulgaria, India, Turkey, Vietnam, Japan, France, Egypt, Malaysia, Taiwan, Thailand, Brazil, Greece, Belgium, Hong... and more